1-Jun-2025 Adding immune checkpoint inhibitor to standard chemotherapy regimen improves outcomes in stage 3 colon cancer, study finds Dana-Farber Cancer Institute Reports and Proceedings
1-Jun-2025 Diet influences survival after stage iii colon cancer, Dana-Farber study finds Dana-Farber Cancer Institute Reports and Proceedings
1-Jun-2025 Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes Weill Cornell Medicine Peer-Reviewed Publication
1-Jun-2025 Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025 Alliance for Clinical Trials in Oncology Peer-Reviewed Publication
1-Jun-2025 Dual-target CAR T cell therapy slows growth of aggressive brain cancer University of Pennsylvania School of Medicine Peer-Reviewed Publication
31-May-2025 ASCO: Pre-surgical combination therapy boosts survival in patients with rare thyroid cancer University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
31-May-2025 ADC combination outperforms standard treatment of advanced triple-negative breast cancer Dana-Farber Cancer Institute Reports and Proceedings
31-May-2025 ‘Magnificent 7’ combo treatment for pancreatic cancer presented today at international forum by HonorHealth Research Institute HonorHealth Research Institute Reports and Proceedings
31-May-2025 Insights from immunotherapy trial inform new approaches to treating advanced skin cancer University of Pittsburgh Peer-Reviewed Publication
31-May-2025 Alliance trial shows dual immunotherapy improves progression-free survival in advanced squamous cell skin cancer Alliance for Clinical Trials in Oncology Peer-Reviewed Publication